Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pizza

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Vaccine|March 21, 2001
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvantsM Pizza, M M Giuliani, M R Fontana, et al.
Vaccine|January 4, 2001
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal deliveryE A McNeela, D O'Connor, I Jabbal-Gill, et al.
The Journal of Experimental Medicine|December 1, 1994
A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunitM Pizza, M R Fontana, M M Giuliani, et al.
Science (New York, N.Y.)|October 27, 1989
Mutants of pertussis toxin suitable for vaccine developmentM Pizza, A Covacci, A Bartoloni, et al.
Molecular Microbiology|October 1, 1994
Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesisM Pizza, M Domenighini, W Hol, et al.
Diabetes|August 21, 2025
Investigating Late-Stage Diabetic Retinopathy: A Long-term Analysis of Vascular Changes in the Streptozotocin-Induced Mouse ModelMadison E Weiss, Milin J Patel, Brandon H Watts, et al.
Vaccine|March 5, 2025
Identification of immunogenic outer membrane vesicle vaccine antigen components using a meningococcal protein microarrayF Ramirez-Bencomo, A Thistlethwaite, V Viviani, et al.
Infection and Immunity|December 11, 1997
Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfectionP Ghiara, M Rossi, M Marchetti, et al.
Vaccine|June 2, 1998
Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvantM Marchetti, M Rossi, V Giannelli, et al.
Scientific Reports|March 1, 2018
Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopesM Giuliani, E Bartolini, B Galli, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Vaccine|March 21, 2001
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvantsM Pizza, M M Giuliani, M R Fontana, et al.
Vaccine|January 4, 2001
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal deliveryE A McNeela, D O'Connor, I Jabbal-Gill, et al.
The Journal of Experimental Medicine|December 1, 1994
A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunitM Pizza, M R Fontana, M M Giuliani, et al.
Science (New York, N.Y.)|October 27, 1989
Mutants of pertussis toxin suitable for vaccine developmentM Pizza, A Covacci, A Bartoloni, et al.
Molecular Microbiology|October 1, 1994
Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesisM Pizza, M Domenighini, W Hol, et al.
Diabetes|August 21, 2025
Investigating Late-Stage Diabetic Retinopathy: A Long-term Analysis of Vascular Changes in the Streptozotocin-Induced Mouse ModelMadison E Weiss, Milin J Patel, Brandon H Watts, et al.
Vaccine|March 5, 2025
Identification of immunogenic outer membrane vesicle vaccine antigen components using a meningococcal protein microarrayF Ramirez-Bencomo, A Thistlethwaite, V Viviani, et al.
Infection and Immunity|December 11, 1997
Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfectionP Ghiara, M Rossi, M Marchetti, et al.
Vaccine|June 2, 1998
Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvantM Marchetti, M Rossi, V Giannelli, et al.
Scientific Reports|March 1, 2018
Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopesM Giuliani, E Bartolini, B Galli, et al.
Pageof 8